Editorial Contributor
Thomas C Novelli is director of federal affairs at the Medical Device Manufacturers Association (MDMA), a national trade association that represents innovative manufacturers of medical devices, diagnostic products and healthcare information systems.
Device tax, new regulations and effectiveness research are causing some panic among medical manufacturers in the US.
The implementation of a new device tax under consideration in the US will not only impact patient access and jobs.
The medical and pharma industries are waiting to hear the results of the main US review of advertising procedures.
Copying, counterfeiting and lack of property rights have made the West wary of working with Chinese manufacturers.
How will the election of President Barack Obama in the US affect medical care globally?
Can medical innovation fight back against the pressures of funding and patent protection?
Healthcare expenditure is continuing to rise as more treatment options become available.
Freebies from drug and device companies may have a biased effect on which treatments physicians choose to prescribe.
